CHALLENGE
Our client, a leading manufacturer and marketer of diagnostic devices, was acquired in 2018 by a private equity firm. As part of an aggressive growth strategy, the company entered into a JV with a leading manufacturer in a new subcategory.
Within the agreement, the organization was responsible for A) the development of the digital ecosystem to support patients, HCPs and caregivers, and B) the marketing and commercialization of this product globally.
Integration was asked to support in the planning and execution of the development and launch program for primary target markets (USA and Germany).
APPROACH
Integration provided immediate and effective PMO support to manage the commercial launch of this new product:
1. Developing a detailed plan with all activities that needed to be carried out for the product development, regulatory submission and commercial launch in the USA – built together with workstream leaders through individual and cross-functional planning workshops.
2. Establishing and managing a governance model to bring a more effective cadence and rhythm to the project’s execution.
3. Detailing a budget plan for the commercial launch.
4. Planning Germany launch strategy for a direct to patient model, working with local experts.
- Optimized plan for USA regulatory submission, with multiple scenarios created based on risk levels, across 10 workstreams (+750 activities outlined).
- Implemented governance cadence, with weekly monitoring of workstreams and progress on strategic partnership. Handover and tools provided to internal PM resources.
- Launch plan including all global activities and local milestones for its initial USA launch, across 17 workstreams (+1350 activities mapped).
- Direct-to-patient Germany launch model planned.